DEMAND Program
General Information
ISN has partnered with the
International Diabetes Federation
, Bristol-Myers Squibb, and Sanofi-Synth?labo to launch an innovative worldwide screening and education campaign.
DEMAND
(Developing Education on Microalbuminuria for Awareness of ReNal and cardiovascular risk in Diabetics) seeks to increase the awareness of microalbuminuria as a renal and cardiovascular risk marker in people with type 2 diabetes, especially if they also have hypertension.
Please visit the DEMAND
website
for more information about the campaign.
|
